ArticleEuropean urology open science2021

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.

Michal Mego et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.